[go: up one dir, main page]

ES485798A1 - Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos. - Google Patents

Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos.

Info

Publication number
ES485798A1
ES485798A1 ES485798A ES485798A ES485798A1 ES 485798 A1 ES485798 A1 ES 485798A1 ES 485798 A ES485798 A ES 485798A ES 485798 A ES485798 A ES 485798A ES 485798 A1 ES485798 A1 ES 485798A1
Authority
ES
Spain
Prior art keywords
dihydro
chloro
carboxylic acid
benzopyran
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485798A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES485798A1 publication Critical patent/ES485798A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen nuevos ácidos benzopiran-4-carboxílicos, ácidos benzotiopiran-4-carboxílicos y derivados de los mismos, sustituidos con halógenos, útiles como inhibidores de la aldosa- reductasa y como agentes terapéuticos para el tratamiento de las complicaciones diabéticas crónicas. Entre los compuestos específicos descritos se encuentran el ácido-6-fenil-8-cloro- 3,4-dihidro-2h,1-benzopiran-4-carboxílico, ácido 6,7-dicloro.3,4-dihidrobenzotiopiran-4- carboxílico, ácido 6-cloro-8-metil-3,4-dihidrobenzotiopiran-4-carboxílico, ácido 6,8-dicloro- 3,4-dihidro-2H-1,benzopiran-4-carboxílico, ácido 6-flúor-3,4-dihidro-2H-1-benzopiran-4- carboxílico, ácido 6-cloro-3,4-dihidro-2H-1-beenzopiran-4-carboxílico, ácido 6-cloro 3,4- dihidro-2H-nafto[1,2-b]piran-4-carboxílico, ácido 6-cloro -3,4-dihidro-2H-1-benzotiopiran-4- carboxílico y ácido 6-cloro-3,4-dihidro-2H-1-benzopiran-4-acético. También se describen composiciones farmacéuticas que contienen los nuevos compuestos y un método de utilización de losnuevos compuestos para el tratamiento de las complicaciones diabéticas crónicas.
ES485798A 1978-11-08 1979-11-07 Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos. Expired ES485798A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/959,023 US4210663A (en) 1978-11-08 1978-11-08 Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids

Publications (1)

Publication Number Publication Date
ES485798A1 true ES485798A1 (es) 1980-10-01

Family

ID=25501572

Family Applications (1)

Application Number Title Priority Date Filing Date
ES485798A Expired ES485798A1 (es) 1978-11-08 1979-11-07 Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos.

Country Status (16)

Country Link
US (1) US4210663A (es)
EP (1) EP0011426B1 (es)
JP (2) JPS6033433B2 (es)
KR (1) KR830001821B1 (es)
AR (1) AR223195A1 (es)
AT (1) AT366680B (es)
AU (1) AU513399B2 (es)
CA (1) CA1132584A (es)
DE (1) DE2965755D1 (es)
DK (1) DK153947C (es)
ES (1) ES485798A1 (es)
FI (1) FI71139C (es)
IE (1) IE49109B1 (es)
IL (1) IL58656A (es)
PT (1) PT70420A (es)
YU (1) YU41675B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4537920A (en) * 1983-08-18 1985-08-27 Ethyl Corporation 4H-1-benzopyrans and lubricant compositions containing same
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
DE69128477T2 (de) * 1990-07-27 1998-07-16 Chugai Seiyaku K.K., Tokio/Tokyo Benzopyranderivat
WO1992014439A1 (fr) * 1991-02-18 1992-09-03 Chugai Seiyaku Kabushiki Kaisha Agent stimulant la croissance des cheveux
US5407897A (en) * 1993-03-03 1995-04-18 American Cyanamid Company Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds
AU2440599A (en) * 1998-02-25 1999-09-15 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
US7288279B2 (en) * 2001-12-21 2007-10-30 Michael Foods Of Delaware, Inc. Formulated fried egg product
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Jnc株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
JP5956920B2 (ja) 2012-12-14 2016-07-27 株式会社コガネイ 液体供給装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
DK471079A (da) 1980-05-09
JPS5585582A (en) 1980-06-27
IL58656A0 (en) 1980-02-29
FI71139C (fi) 1986-11-24
KR830001273A (ko) 1983-04-30
JPS6113716B2 (es) 1986-04-15
YU269779A (en) 1983-02-28
AR223195A1 (es) 1981-07-31
AU5258279A (en) 1980-05-15
FI793487A7 (fi) 1980-05-09
JPS6033433B2 (ja) 1985-08-02
US4210663A (en) 1980-07-01
YU41675B (en) 1987-12-31
DE2965755D1 (en) 1983-07-28
KR830001821B1 (ko) 1983-09-12
CA1132584A (en) 1982-09-28
JPS56103176A (en) 1981-08-18
DK153947C (da) 1989-02-20
AT366680B (de) 1982-04-26
IL58656A (en) 1983-06-15
FI71139B (fi) 1986-08-14
IE49109B1 (en) 1985-08-07
PT70420A (de) 1979-12-01
EP0011426A1 (en) 1980-05-28
ATA719279A (de) 1981-09-15
DK153947B (da) 1988-09-26
AU513399B2 (en) 1980-11-27
IE792136L (en) 1980-05-08
EP0011426B1 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
ES485798A1 (es) Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos.
ES475040A1 (es) Un procedimiento para la produccion de nuevos derivados de octahidrofenantreno
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE7906949L (sv) Nya spiro-oxazolidindioner
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
ES2061452T3 (es) Nuevas hetrazepinas y procedimiento para su preparacion.
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES476955A1 (es) Un procedimiento para la preparacion de derivados se imida- zoquinazolina.
ES2082755T3 (es) Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios.
ES8605377A1 (es) Compuesto farmaceutico apropiado para administracion por via intestinal
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
ES2038679T3 (es) Un procedimiento para preparar derivados de dihidrobenzofurano- y cromano-carboxamidas.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
PT83478B (pt) Processo para a prepracao de novos derivados polioxigenados de labdano e de composicoes farmaceuticas que os contem
MX9207557A (es) Derivados de acidos benzofuranil- y tiofenilmetiltio-alcanocarboxilicos, procedimiento para su preparacion y medicamentos que los contienen.
MY103595A (en) (arylsulphonyl) nitromethanes, process for their preparation and use in pharmaceutical compositions
ES8106152A1 (es) Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona.
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.
ES2029466T3 (es) Un metodo para la preparacion de una composicion hidrofoba que contiene enzimas y la composicion producida a partir del mismo.
ES532124A0 (es) Un procedimiento para preparar derivados de acido 4, 7-dihidropirazolo (3, 4-b) piridin-5-carboxilico
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
ES8307200A1 (es) Un procedimiento para la preparacion de derivados tetrasubs-tituidos del benceno.
DK260382A (da) Benzo(4,5)pyrano(2,3c)pyrroler,fremgangsmaader til deres fremstilling og farmaceutiske produkter indeholdende disse
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.